{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:04:08Z","timestamp":1777478648065,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    Acute ischemic stroke (AIS) patients with congestive heart failure (HF) that present with various risk factors are less likely to receive recombinant tissue plasminogen activator (rtPA). The risk factors associated with excluding AIS patients with congestive heart failure (AIS-HF) from rtPA therapy have not been fully established.\n                    <jats:bold>Methods:<\/jats:bold>\n                    Retrospective data for 5469 AIS patients comprised of 590 AIS patients with HF and 4879 AIS patients without HF were collected from a regional stroke registry between January 2010 and June 2016. Baseline risk factors were analyzed using logistic regression analysis to determine the risk factors associated with rtPA exclusion in AIS-HF patients.\n                    <jats:bold>Results:<\/jats:bold>\n                    In the adjusted analysis, AIS-HF patients that that did not receive rtPA were more likely to be older (OR\u2009=\u20090.982, 95% CI, 0.966-1,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.020), presented with coronary artery disease (OR\u2009=\u20090.618, 95% CI, 0.391-0.98,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.040), and with an elevated INR (OR\u2009=\u20090.326, 95% CI, 0.129-0.82,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.018). AIS-HF patients that were included for rtPA therapy were more likely to show improvement in ambulatory status (OR\u2009=\u20091.69, 95% CI, 1.058-2.7,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.028). The discriminating power of the model was strong with an area under the curve (AUROC)\u2009=\u20090.668 (95% CI, 0.611-0.724,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001).\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Our study establishes the associations between stroke risk factors and exclusion from rtPA therapy. This finding suggests the need to develop management strategies for older HF patients with carotid artery disease and an elevated INR to improve their eligibility for rtPA treatment following an acute ischemic stroke.\n                  <\/jats:p>","DOI":"10.1177\/10760296221116347","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T22:21:36Z","timestamp":1666477296000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy"],"prefix":"10.1177","volume":"28","author":[{"given":"Carolyn Breauna","family":"Sanders","sequence":"first","affiliation":[{"name":"School of Medicine Greenville, University of South Carolina, Greenville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Knisely","sequence":"additional","affiliation":[{"name":"School of Medicine Greenville, University of South Carolina, Greenville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase","family":"Rathfoot","sequence":"additional","affiliation":[{"name":"School of Medicine Greenville, University of South Carolina, Greenville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camron","family":"Edrissi","sequence":"additional","affiliation":[{"name":"School of Medicine Greenville, University of South Carolina, Greenville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-5050","authenticated-orcid":false,"given":"Thomas","family":"Nathaniel","sequence":"additional","affiliation":[{"name":"School of Medicine Greenville, University of South Carolina, Greenville"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.628479"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.218"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.03.021"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.005"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.026139"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.028624"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.019889"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","unstructured":"Siedler G Sommer K Macha K et al. Heart failure in ischemic stroke. 2019;50(11):3051\u20103056. doi:10.1161\/STROKEAHA.119.026139.","DOI":"10.1161\/STROKEAHA.119.026139"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000156"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:25:2"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190313112841"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023870"},{"key":"e_1_3_4_15_2","first-page":"34","article-title":"Thrombolytic therapy in ischemic stroke patients with a preceding transient ischemic attack (TIA) in a telestroke and non-telestroke setting","volume":"5","author":"Poupore N","year":"2020","unstructured":"Poupore N, Strat D, Mackey T, Brown K, Snell A, Nathaniel IT. Thrombolytic therapy in ischemic stroke patients with a preceding transient ischemic attack (TIA) in a telestroke and non-telestroke setting. Neurol Clin Neurosci. 2020;5:34\u201039.","journal-title":"Neurol Clin Neurosci."},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-1007-y"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.20517\/2347-8659.2015.46"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2018.08.003"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010743"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2012.03.015"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.2174\/157340310791658776"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01782-5"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620906867"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620906867"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2021.04.003"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01270-2"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02214-8"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001877"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32834a764e"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/1941874415578532"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/1941874419879813"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000006"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002716"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.645986"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.4066\/AMJ.2013.1607"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2019.01.002"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","unstructured":"Poupore N Strat D Mackey T Snell A Nathaniel T. Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours: Predicting clinical risk factors for thrombolytic therapy. Research Square; 2019.","DOI":"10.21203\/rs.2.17137\/v1"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.03.001"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0870-x"},{"issue":"2","key":"e_1_3_4_40_2","first-page":"1","article-title":"Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratio","volume":"6","author":"Aggarwal HR","year":"2013","unstructured":"Aggarwal HR, Hassan AE, Rodriguez GJ, Suri MF, Taylor RA, Qureshi AI. Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratio. J Vasc Interv Neurol. 2013;6(2):1\u20108.","journal-title":"J Vasc Interv Neurol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e3181f7d043"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70130-3"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs0202.102599"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183702.04080.27"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl104"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.05.012"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-019-0421-2"},{"issue":"1","key":"e_1_3_4_48_2","first-page":"3","article-title":"Contraindications and exclusion criteria in guidelines for rt-pa in acute ischemic stroke: can the new aha\/asa guideline expand the use of rt-pa?","volume":"68","author":"Nathaniel TI","year":"2016","unstructured":"Nathaniel TI, Williams JA, Fazzone B, et al. Contraindications and exclusion criteria in guidelines for rt-pa in acute ischemic stroke: can the new aha\/asa guideline expand the use of rt-pa? Hypertension. 2016;68(Suppl 1):3-6.","journal-title":"Hypertension"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.12.001"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.623199"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr030"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2016.1186840"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c5b46d"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996419"},{"key":"e_1_3_4_55_2","volume-title":"International Normalized Ratio (INR)","author":"Shikdar S","year":"2022","unstructured":"Shikdar S, Vashisht R, Bhattacharya PT. International Normalized Ratio (INR). StatPearls Publishing; 2022."},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3233\/RNN-140480"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296221116347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296221116347","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296221116347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:03:29Z","timestamp":1777385009000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296221116347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"alternative-id":["10.1177\/10760296221116347"],"URL":"https:\/\/doi.org\/10.1177\/10760296221116347","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"10760296221116347"}}